Univariate Univariate Multivariate Multivariate Multivariate
HR(95% Cl)
p-value
p-value
HR(95%Cl) p-value HR(95%Cl) p-value
Age(≤49 vs. >49 years) 0.71 (0.29-1.72) 0.451 0.451
PARPi monotherapy (Yes vs. No) 0.36 (0.15-0.92) 0.032* 0.032* 0.33 (0.12-0.94) 0.038*
Residual Lesions(R0 vs. R1+R2) 0.29 (0.11-0.78) 0.014* 0.014* 0.42 (0.15-1.17) 0.097
BRCA mutation (1 vs. 2) 0.60 (0.17-2.07) 0.416 0.416
Stage at diagnosis (I or II vs. III or IV) 0.18 (0.24-1.35) 0.096 0.096 0.33 (0.04-2.74)- 0.305
Cytoreductive surgery (NAC-IDS vs. PDS) 0.42 (0.12-1.47) 0.174 0.174
1st PFI (5-12 vs. >12 months) 0.56 (0.23-1.38) 0.208 0.208
2nd PFI (6-12 vs. >12 months) 0.58 (0.19-1.75) 0.334 0.334
CA-125 at secondary recurrence (≤70 vs. >70 U/ml) 0.62 (0.21-1.88) 0.400 0.400